Trials / Unknown
UnknownNCT03366597
The Research of the Effect of Sevoflurane on Brain-protection of Cardiac Surgery in Infants.
Effect of Sevoflurane on the Content of S100β in Infants With Congenital Heart Disease Undergo Cardiac Surgery.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Jun Ma · Academic / Other
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
To observe the effect of sevoflurane on the concentration of S100β and regional cerebral oxygen saturation in infants with congenital heart disease undergoing cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | 1.5%-3% Sevoflurane will be given during the cardiac surgery except cardiopulmonary bypass. |
Timeline
- Start date
- 2018-01-20
- Primary completion
- 2021-12-28
- Completion
- 2022-12-28
- First posted
- 2017-12-08
- Last updated
- 2021-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03366597. Inclusion in this directory is not an endorsement.